Company intelligence / Profile preview

Bio-Gels Pharmaceuticals

Ownership: Private
Development stage: Other

Overview

Bio-Gels Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of advanced topical drug delivery systems. The company utilizes its proprietary Bio-Gel technology to enhance the penetration and efficacy of active pharmaceutical ingredients through the skin. Their product portfolio primarily addresses needs in pain management and wound care, offering alternatives to systemic treatments. By leveraging hydrogel-based formulations, Bio-Gels aims to provide sustained-release therapeutic benefits with reduced side effects.

Therapeutic areas: DermatologyNeurology
Modalities: Hydrogel-based drug delivery therapySmall molecule
Industry: Biotech

Drug pipeline

1 asset

monocaprin

Unknown

Beyond the preview

Go deeper on Bio-Gels Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Gels Pharmaceuticals.

Explore the full profile